Skip to main content

Research by Haley Moss, MD, MBA, Published in JAMA Oncology

Wednesday, December 13, 2017

Research by Haley A. Moss, MD, MBA, Gynecological Oncology Fellow, and colleagues, shows that multimodal screening (MMS) for ovarian cancer is potentially cost-effective in the U.S. The study has been published in JAMA Oncology. An article on the research appears in the December 8, 2017 edition of HealthDay.